I just answered Amatuer post on the other board but it was deleted ,

I hope you don't mind if I post it here ....

Amatuer ...

I don't know from where you are taking some of your information here..
During shareholders meeting Dr NP said that we will need about 160 patients for pivotal mono , so how you got this number of 350...

Also FDA is working closely with our company to design good protocol , it might be ready sooner than two months , and we not sure if it will be 48 months maintenance ...

When combo will be approved by the end of this year or beginning of 2020 , most probably TNBC and maybe even another cancer , like colon probably will also be approve by this time ...

Few months this way or this way is no more important ,
Especially that most of us think that by this time CYDY will not be standing as independent company...

I don't know BO , partnership , licensing ...things will happen..

And when combo will be approved we on the way to big revenue on the spot.

In USA predicted for 2020 over 185,000 MDR 2 , CCR5 positive patients ,
and over 7,500-8000 MDR 3 , CCR5 positive...

And they planing to apply in Europe asap , and Europe is twice as big.

So few months this or this way is not important now , results are !!!

And our results are as no other.!!!!!!

And during yesterday interview at about 5:10 , Dr NP said that enrollment for pivotal mono is almost to fast , so how you got 9-12 months.....

One thing I need to give you , you spending a lot of time and energy to present every positive news in negative spin..

GLTU